garenoxacin has been researched along with norfloxacin in 4 studies
Studies (garenoxacin) | Trials (garenoxacin) | Recent Studies (post-2010) (garenoxacin) | Studies (norfloxacin) | Trials (norfloxacin) | Recent Studies (post-2010) (norfloxacin) |
---|---|---|---|---|---|
195 | 19 | 46 | 3,077 | 280 | 912 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, Z; Deng, Y; Li, Y; Luo, L; Qiang, X; Song, Q; Tan, Z; Xiao, G; Xu, R; Yang, X | 1 |
Blaskovich, MAT; Pham, TDM; Ziora, ZM | 1 |
Andrews, JM; Boswell, FJ; Wise, R | 1 |
Fukumoto, H; Furubo, S; Hayakawa, H; Kawamura, Y; Kizawa, K; Miyazaki, M; Morita, T; Nagai, A; Sanzen, T | 1 |
1 review(s) available for garenoxacin and norfloxacin
Article | Year |
---|---|
Quinolone antibiotics.
Topics: | 2019 |
3 other study(ies) available for garenoxacin and norfloxacin
Article | Year |
---|---|
Multifunctional thioxanthone derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Cell Line; Cholinesterase Inhibitors; Humans; Kinetics; Models, Molecular; Monoamine Oxidase Inhibitors; Thioxanthenes; Xanthones | 2017 |
Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Fluoroquinolones; Humans; Indoles; Microbial Sensitivity Tests; Moxifloxacin; Norfloxacin; Quinolines; Quinolones; Streptococcus pneumoniae | 2001 |
Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Cartilage, Articular; Ciprofloxacin; Dogs; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Indoles; Injections, Intravenous; Joint Diseases; Male; Norfloxacin; Quinolones; Toxicity Tests | 2002 |